143 related articles for article (PubMed ID: 9678648)
1. A new approach to the light/dark test procedure in mice.
Hascoët M; Bourin M
Pharmacol Biochem Behav; 1998 Jul; 60(3):645-53. PubMed ID: 9678648
[TBL] [Abstract][Full Text] [Related]
2. A fully automated light/dark apparatus useful for comparing anxiolytic agents.
Young R; Johnson DN
Pharmacol Biochem Behav; 1991 Dec; 40(4):739-43. PubMed ID: 1687762
[TBL] [Abstract][Full Text] [Related]
3. Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
Ago Y; Takahashi K; Nakamura S; Hashimoto H; Baba A; Matsuda T
J Pharmacol Sci; 2007 Jun; 104(2):153-8. PubMed ID: 17538228
[TBL] [Abstract][Full Text] [Related]
4. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
Shimada T; Matsumoto K; Osanai M; Matsuda H; Terasawa K; Watanabe H
Gen Pharmacol; 1995 Jan; 26(1):205-10. PubMed ID: 7713361
[TBL] [Abstract][Full Text] [Related]
5. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
Fernandez F; Misilmeri MA; Felger JC; Devine DP
Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.
Bradley BF; Bridges NJ; Starkey NJ; Brown SL; Lea RW
Behav Brain Res; 2011 Jan; 216(1):285-92. PubMed ID: 20723567
[TBL] [Abstract][Full Text] [Related]
8. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
Kuribara H; Stavinoha WB; Maruyama Y
J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634
[TBL] [Abstract][Full Text] [Related]
9. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the open-field and light/dark tests.
Heredia L; Torrente M; Colomina MT; Domingo JL
J Pharmacol Toxicol Methods; 2014; 69(2):108-14. PubMed ID: 24374104
[TBL] [Abstract][Full Text] [Related]
10. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test.
Raud S; Innos J; Abramov U; Reimets A; Kõks S; Soosaar A; Matsui T; Vasar E
Psychopharmacology (Berl); 2005 Sep; 181(2):347-57. PubMed ID: 15830228
[TBL] [Abstract][Full Text] [Related]
11. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.
Takeda H; Tsuji M; Matsumiya T
Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010
[TBL] [Abstract][Full Text] [Related]
12. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
Merlo Pich E; Samanin R
Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
[TBL] [Abstract][Full Text] [Related]
13. Behavioural effects of anxiogenic agents in the common marmoset.
Carey GJ; Costall B; Domeney AM; Jones DN; Naylor RJ
Pharmacol Biochem Behav; 1992 May; 42(1):143-53. PubMed ID: 1528937
[TBL] [Abstract][Full Text] [Related]
14. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.
Kalouda T; Pitsikas N
Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of paeonol in mice.
Mi XJ; Chen SW; Wang WJ; Wang R; Zhang YJ; Li WJ; Li YL
Pharmacol Biochem Behav; 2005 Jul; 81(3):683-7. PubMed ID: 15970315
[TBL] [Abstract][Full Text] [Related]
16. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
[TBL] [Abstract][Full Text] [Related]
17. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice.
Imaizumi M; Suzuki T; Machida H; Onodera K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):83-91. PubMed ID: 7913786
[TBL] [Abstract][Full Text] [Related]
18. Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
Campos KF; Amaral VC; Rico JL; Miguel TT; Nunes-de-Souza RL
Behav Brain Res; 2013 Mar; 240():160-70. PubMed ID: 23195112
[TBL] [Abstract][Full Text] [Related]
19. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the zero maze test.
Heredia L; Torrente M; Colomina MT; Domingo JL
J Pharmacol Toxicol Methods; 2013; 68(2):275-283. PubMed ID: 23499652
[TBL] [Abstract][Full Text] [Related]
20. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
Kliethermes CL; Finn DA; Crabbe JC
Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
